Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma

Emre Güven; Yusuf Can Edek; Funda Tamer; Özlem Erdem

doi:10.5826/dpc.1404a243

Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma

Authors

Emre Güven Gazi University Faculty of Medicine, Department of Dermatology
Yusuf Can Edek Gazi University Faculty of Medicine, Department of Dermatology https://orcid.org/0000-0002-3877-8681
Funda Tamer Gazi University Faculty of Medicine, Department of Dermatology https://orcid.org/0000-0003-4157-5583
Özlem Erdem Gazi University Faculty of Medicine, Department of Pathology https://orcid.org/0000-0002-5981-4856

Keywords:

bortezomib, drug reaction

References

Reyes-Habito CM, Roh EK. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs. J Am Acad Dermatol. 2014 Aug;71(2):203.e1-203.e12. doi: 10.1016/j.jaad.2014.04.014.

Han J, Owji S, Agarwal A, et al. Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma. Dermatopathology (Basel). 2023 Jul 21;10(3):226-230. doi: 10.3390/dermatopathology10030031.

Choi GS, Lee HS, Kim HK. A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test. Asia Pac Allergy. 2021 Apr 21;11(2):e17. doi: 10.5415/apallergy.2021.11.e17.

Kurtin S, Knop CS, Milliron T. Subcutaneous administration of bortezomib: strategies to reduce injection site reactions. J Adv Pract Oncol. 2012 Nov;3(6):406-10. doi: 10.6004/jadpro.2012.3.6.8.

Plume MA, Sibaud V, Bobin A, et al. Spider-like injection site reaction after subcutaneous administration of haematological treatments. J Eur Acad Dermatol Venereol. 2020 Mar;34(3):e142-e144. doi: 10.1111/jdv.16049.

Downloads

Published

2024-10-30

Issue

Vol. 14 No. 4 (2024): 2024 Vol 14, No 4 | October

Section

Research Letter

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma. Dermatol Pract Concept [Internet]. 2024 Oct. 30 [cited 2024 Dec. 6];14(4):e2024243. Available from: https://dpcj.org/index.php/dpc/article/view/4454